Updates on HIV nonoccupational postexposure prophylaxis.

PURPOSE OF REVIEW Adolescents and young adults continue to contribute to new HIV infections despite improved antiretroviral regimens and HIV preexposure and postexposure prophylaxis (PrEP and PEP). Knowledge about nonoccupational HIV PEP (nPEP) is relevant and important for all pediatricians as adolescents present under a variety of circumstances disclosing past sexual activity. RECENT FINDINGS nPEP is effective in preventing HIV infection, and newer regimens have been shown to increase compliance amongst users, have less side effects, and lead to less HIV resistance. Yet, research on physician prescription practices shows a lack of knowledge regarding appropriate HIV nPEP medication regimens, dosing, and follow-up recommendations. Updated national guidelines are available to providers who may be unfamiliar with indications and drug regimens for nPEP. Studies also provide different strategies to increase nPEP use and compliance among patients as well as ways to increase provider awareness of appropriate nPEP prescription. SUMMARY Research of HIV nPEP shows that it is effective when used correctly, but there needs to be increased education and awareness to increase provider prescription and patient use as well as institutional changes to help patients complete the full course of medication.

[1]  M. Friend,et al.  Diagnoses of HIV infection in the United States and dependent areas (updated), 2018 , 2020 .

[2]  Y. Hsieh,et al.  Do confidentiality concerns impact pre-exposure prophylaxis willingness in emergency department adolescents and young adults? , 2019, The American journal of emergency medicine.

[3]  G. Baird,et al.  The Provision of HIV Post-Exposure Prophylaxis in the Context of Child Sex Trafficking. , 2018, Rhode Island medical journal.

[4]  Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis , 2018, Canadian Medical Association Journal.

[5]  K. Ethier,et al.  Youth Risk Behavior Surveillance — United States, 2017 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[6]  C. Tseng,et al.  Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County , 2018, International journal of STD & AIDS.

[7]  K. Mayer,et al.  HIV Preexposure Prophylaxis: A Review , 2018, JAMA.

[8]  W. Muller,et al.  Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis. , 2018, Infectious disease clinics of North America.

[9]  H. Trottier,et al.  Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV , 2017, AIDS.

[10]  S. De Wit,et al.  Adherence to HIV post-exposure prophylaxis: A multivariate regression analysis of a 5 years prospective cohort. , 2018, The Journal of infection.

[11]  B. Guthrie,et al.  A Meta‐Analysis of HIV Postexposure Prophylaxis Among Sexually Assaulted Patients in the United States , 2018, The Journal of the Association of Nurses in AIDS Care : JANAC.

[12]  C. Udeagu,et al.  Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015–2017 , 2017, Journal of acquired immune deficiency syndromes.

[13]  Jennifer C. Chang,et al.  HIV Prevention and Treatment: The Evolving Role of the Emergency Department , 2017, Annals of emergency medicine.

[14]  P. Scribano,et al.  Improving HIV post-exposure prophylaxis rates after pediatric acute sexual assault. , 2017, Child abuse & neglect.

[15]  I. Stiell,et al.  Two, three, and four‐drug regimens for HIV post‐exposure prophylaxis in a North American sexual assault victim population , 2017, The American journal of emergency medicine.

[16]  R. Weiss,et al.  Differentiating Nonoccupational Postexposure Prophylaxis Seroconverters and Non-Seroconverters in a Community-Based Clinic in Los Angeles, California , 2017, Open forum infectious diseases.

[17]  E. Kobetz,et al.  HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami , 2016, International journal of STD & AIDS.

[18]  E. Grafstein,et al.  Missed Opportunities for HIV Prophylaxis Among Emergency Department Patients With Occupational and Nonoccupational Body Fluid Exposures. , 2016, Annals of emergency medicine.

[19]  J. Marrazzo,et al.  Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection. , 2016, The Medical clinics of North America.

[20]  D. Hawkins,et al.  UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015 , 2016, International journal of STD & AIDS.

[21]  W. Heneine,et al.  Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016 , 2016 .

[22]  K. Mayer,et al.  The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  N. Ford,et al.  Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  N. Ford,et al.  Efficacy of HIV Postexposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  N. Ford,et al.  Starter packs versus full prescription of antiretroviral drugs for postexposure prophylaxis: a systematic review. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  N. Ford,et al.  Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis , 2014, AIDS.

[27]  Arielle Lasry,et al.  Estimating per-act HIV transmission risk: a systematic review , 2014, AIDS.

[28]  I. Bogoch,et al.  Patient attrition between the emergency department and clinic among individuals presenting for HIV nonoccupational postexposure prophylaxis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  J. Desenclos,et al.  Cost-effectiveness of HIV post-exposure prophylaxis in France , 2006, AIDS.

[30]  J. Kahn,et al.  Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. , 2004, Archives of internal medicine.

[31]  C. Samples,et al.  Postexposure prophylaxis: an intervention to prevent human immunodeficiency virus infection in adolescents , 2003, Current opinion in pediatrics.

[32]  J L Collins,et al.  Youth risk behavior surveillance--United States, 1993. , 1995, The Journal of school health.